HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resistance of clinically important yeasts to antifungal agents.

Abstract
Resistance of yeasts to antifungal agents was a relatively minor clinical problem for many years. Recently Candida albicans isolates resistant to fluconazole have been reported with increasing frequency in the setting of oral infections in HIV-positive patients. Improved standardization of fluconazole susceptibility testing has resulted in demonstrable correlations between yeast resistance in vitro and in vivo for this agent in the AIDS setting. Known resistance mechanisms for azole antifungals include reduced access of the drug to the intracellular sterol demethylase target, probably because of the action of multidrug resistance efflux pumps, and overproduction of that target. Management and prevention of future resistance development requires greater vigilance for surveillance than has been the practice in the past.
AuthorsF C Odds
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 6 Issue 3 Pg. 145-7 (Feb 1996) ISSN: 0924-8579 [Print] Netherlands
PMID18611701 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: